CUFinder

Mehdi Hamadani

Mehdi Hamadani

Medical College of Wisconsin

H-index: 60

North America-United States

Contact Mehdi Hamadani

About Mehdi Hamadani

Mehdi Hamadani, With an exceptional h-index of 60 and a recent h-index of 52 (since 2020), a distinguished researcher at Medical College of Wisconsin, specializes in the field of Lymphoma, Myeloma and Bone Marrow Transplantation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Health-Related Quality of Life with Gilteritinib Versus Placebo Post-Transplant Maintenance for FLT3-ITD+ Acute Myeloid Leukemia (AML): A Quality of Life Analysis from BMT CTN 1506

Lisocabtagene Maraleucel (liso-cel) As Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplantation (HSCT): Final …

Impact of Complete Response (CR) on Long-Term Survival Among Patients Receiving Axicabtagene Ciloleucel (axi-cel) for Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL)

Fresh Versus Cryopreserved LV20. 19 CAR T-Cell Therapy for Relapsed, Refractory DLBCL and Follicular Lymphoma

CD19-Directed CART Therapy for T Cell/Histiocyte Rich Large B-Cell Lymphoma: A CIBMTR Analysis

Clinician and Administrator Perspectives on Chimeric Antigen Receptor (CAR) T-Cell Therapy Outpatient Administration in Relapsed or Refractory Multiple Myeloma (RRMM) in the …

Safety and Efficacy of Axatilimab in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)

Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapy

Mehdi Hamadani Information

University

Position

& CIBMTR

Citations(all)

15399

Citations(since 2020)

11204

Cited By

8301

hIndex(all)

60

hIndex(since 2020)

52

i10Index(all)

271

i10Index(since 2020)

222

Email

University Profile Page

Google Scholar

Mehdi Hamadani Skills & Research Interests

Lymphoma

Myeloma and Bone Marrow Transplantation

Top articles of Mehdi Hamadani

Health-Related Quality of Life with Gilteritinib Versus Placebo Post-Transplant Maintenance for FLT3-ITD+ Acute Myeloid Leukemia (AML): A Quality of Life Analysis from BMT CTN 1506

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Yi-Bin Chen
Yi-Bin Chen

H-Index: 44

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

David Cella
David Cella

H-Index: 108

Lisocabtagene Maraleucel (liso-cel) As Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplantation (HSCT): Final …

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Nina Wagner-Johnston
Nina Wagner-Johnston

H-Index: 36

Zhi Yang
Zhi Yang

H-Index: 7

Leo I Gordon
Leo I Gordon

H-Index: 49

Impact of Complete Response (CR) on Long-Term Survival Among Patients Receiving Axicabtagene Ciloleucel (axi-cel) for Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL)

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Myrna Nahas
Myrna Nahas

H-Index: 7

Timothy Best
Timothy Best

H-Index: 5

Zhen-Huan Hu
Zhen-Huan Hu

H-Index: 14

Marcelo C Pasquini
Marcelo C Pasquini

H-Index: 46

Fresh Versus Cryopreserved LV20. 19 CAR T-Cell Therapy for Relapsed, Refractory DLBCL and Follicular Lymphoma

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Jessica Neumann
Jessica Neumann

H-Index: 7

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

CD19-Directed CART Therapy for T Cell/Histiocyte Rich Large B-Cell Lymphoma: A CIBMTR Analysis

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Clinician and Administrator Perspectives on Chimeric Antigen Receptor (CAR) T-Cell Therapy Outpatient Administration in Relapsed or Refractory Multiple Myeloma (RRMM) in the …

Transplantation and Cellular Therapy

2024/2/1

Binod Dhakal
Binod Dhakal

H-Index: 2

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Tania Jain
Tania Jain

H-Index: 15

Yi-Hsuan Liu
Yi-Hsuan Liu

H-Index: 0

Safety and Efficacy of Axatilimab in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)

Transplantation and Cellular Therapy

2024/2/1

Jennifer White
Jennifer White

H-Index: 16

Fabio Ciceri
Fabio Ciceri

H-Index: 29

Chuan Tian
Chuan Tian

H-Index: 7

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapy

2024/2

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Razan Mohty
Razan Mohty

H-Index: 4

Infectious and Non-Infectious Pulmonary Complications in HCT Patients Treated with Post Transplant Cyclophosphamide (PTCy) Based Gvhd Prophylaxis

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Sameem Abedin
Sameem Abedin

H-Index: 10

ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Relapsed Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T-Cell Therapy

Transplantation and Cellular Therapy

2024/4/12

Ambuj Kumar
Ambuj Kumar

H-Index: 11

Tania Jain
Tania Jain

H-Index: 15

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Binod Dhakal
Binod Dhakal

H-Index: 2

Phase 1 Trial of LV20. 19 CAR T-Cells for Relapsed, Refractory CLL and Richter's Transformation

Transplantation and Cellular Therapy

2024/2/1

Sameem Abedin
Sameem Abedin

H-Index: 10

Guru Subramanian Guru Murthy
Guru Subramanian Guru Murthy

H-Index: 11

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

In relapsed or refractory diffuse large B‐cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine

Ejhaem

2024/2

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Ying Wang
Ying Wang

H-Index: 3

Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World Analysis

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Anthony D Sung
Anthony D Sung

H-Index: 18

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Gulrayz Ahmed
Gulrayz Ahmed

H-Index: 6

Nosha Farhadfar
Nosha Farhadfar

H-Index: 11

Kuo-Kai Chin
Kuo-Kai Chin

H-Index: 4

Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20+ B Cell Lymphoma

Transplantation and Cellular Therapy

2024/2/1

Javier Munoz
Javier Munoz

H-Index: 16

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen

Blood Advances

2024/4/9

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Shuo Ma
Shuo Ma

H-Index: 15

Valerie Nelson
Valerie Nelson

H-Index: 12

Andreas Klein
Andreas Klein

H-Index: 37

Irene Helenowski
Irene Helenowski

H-Index: 31

Xinlei Mi
Xinlei Mi

H-Index: 5

A Multicenter Experience: Duration of Mandatory CRS and Icans Monitoring for Myeloma and Lymphoma CAR-T Recipients

Transplantation and Cellular Therapy

2024/2/1

Danai Dima
Danai Dima

H-Index: 27

James Davis
James Davis

H-Index: 12

Forat Lutfi
Forat Lutfi

H-Index: 3

Marc Hoffmann
Marc Hoffmann

H-Index: 18

Al-Ola Abdallah
Al-Ola Abdallah

H-Index: 7

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial

Blood advances

2024/1/9

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Xiaolei Zhou
Xiaolei Zhou

H-Index: 6

Lei Chen
Lei Chen

H-Index: 18

John Radford
John Radford

H-Index: 47

Juan Pablo Alderuccio
Juan Pablo Alderuccio

H-Index: 7

Ying Wang
Ying Wang

H-Index: 3

Pier Luigi Zinzani
Pier Luigi Zinzani

H-Index: 67

PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial

Clinical cancer research

2024/1/5

Juan Pablo Alderuccio
Juan Pablo Alderuccio

H-Index: 7

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

John Radford
John Radford

H-Index: 47

Pier Luigi Zinzani
Pier Luigi Zinzani

H-Index: 67

Fei Yang
Fei Yang

H-Index: 1

Outpatient Administration of Commercial antiCD19 and Antibcma Chimeric Antigen Receptor-Modified T-Cell (CAR-T) Therapies Using a Strategy of No Remote Monitoring and Early …

Transplantation and Cellular Therapy

2024/2/1

Anita D'Souza
Anita D'Souza

H-Index: 25

Marcelo C Pasquini
Marcelo C Pasquini

H-Index: 46

Guru Subramanian Guru Murthy
Guru Subramanian Guru Murthy

H-Index: 11

Sameem Abedin
Sameem Abedin

H-Index: 10

Meera Mohan
Meera Mohan

H-Index: 6

Binod Dhakal
Binod Dhakal

H-Index: 2

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic …

Bone Marrow Transplantation

2024/1/4

Kathleen Monahan
Kathleen Monahan

H-Index: 8

Sameem Abedin
Sameem Abedin

H-Index: 10

Marcelo C Pasquini
Marcelo C Pasquini

H-Index: 46

Wael Saber
Wael Saber

H-Index: 36

Binod Dhakal
Binod Dhakal

H-Index: 2

Meera Mohan
Meera Mohan

H-Index: 6

Mehdi Hamadani
Mehdi Hamadani

H-Index: 40

See List of Professors in Mehdi Hamadani University(Medical College of Wisconsin)

Co-Authors

academic-engine

Useful Links

List of top 50 universities
List of top 100 universities
List of top 500 universities
Find Professors Email
Find Universities Email
CUFinder Academic Engine